Showing 1,664 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C treatment

How Sure Is a Cure?

Editor's pick
Poz
20 July 2015
Hepatitis C treatment

Gilead Limits Enrollment in its Hep C Patient Program to Pressure Insurers

Editor's pick
Wall Street Journal Pharmalot blog
20 July 2015
Hepatitis C treatment

Gilead Limits Enrollment in its Hep C Patient Program to Pressure Insurers

Editor's pick
Wall Street Journal
19 July 2015
Pharmaceutical industry

TAG Pipeline Report

Editor's pick
TAG
17 July 2015
People who inject drugs

Improving access to, and completion of, hepatitis C treatment

Editor's pick
Public Health England
17 July 2015
Hepatitis B

Drug Resistance Common Among European Patients With Chronic Hepatitis B

Editor's pick
Medscape
14 July 2015
New & experimental hepatitis C treatment

Gilead pills priced at $1,000 a day are found cost-effective

Editor's pick
Bloomberg
14 July 2015
New & experimental hepatitis C treatment

Leading Canadian researcher calls for inclusion of co-infected people in large HCV clinical trials

Editor's pick
CATIE
7 July 2015
Access to healthcare

The Medicines Patent Pool Releases Independent Feasibility Studies on Hepatitis C and Tuberculosis

Editor's pick
Medicines Patent Pool
7 July 2015
Hepatitis C symptoms & diagnosis

US: Hepatitis C Rising -- Especially Among Young People -- and May Be Underestimated

Editor's pick
HIVandHepatitis.com
6 July 2015
Hepatitis C symptoms & diagnosis

Public health surveillance system may underestimate cases of acute hepatitis C infection

Editor's pick
Eurekalert Inf Dis
2 July 2015
Hepatitis C treatment

National study finds life-threatening barriers in access to breakthrough drugs

Editor's pick
Eurekalert
30 June 2015
New & experimental hepatitis C treatment

FDA is Sued by Advocacy Groups That Want Gilead Hepatitis C Trial Data

Editor's pick
Wall Street Journal (blog)
29 June 2015
Hepatitis C treatment

Adding ribavirin to Harvoni for hepatitis C increases side effects but not efficacy

Editor's pick
HIVandHepatitis.com
29 June 2015
Hepatitis C symptoms & diagnosis

Hepatitis C Virus Infection and Alcohol: Challenges and Opportunities

Editor's pick
HCV Action
24 June 2015
Hepatitis C treatment

AbbVie Announces New Phase 3b Results in Genotype 1b Chronic Hepatitis C Patients with Compensated Liver Cirrhosis

Editor's pick
AbbVie press release
24 June 2015
Hepatitis C treatment

Burman's Specialty Pharmacy study shows hepatitis C cure possible while cutting a third of the drug costs

Editor's pick
Burman's Specialty Pharmacy press release
24 June 2015
Access to healthcare

China rejects Gilead hepatitis C drug patent: advocacy group

Editor's pick
Reuters
19 June 2015
Hepatitis C treatment

Hepatitis C: 25 Years Old, and Fading

Editor's pick
Medscape
17 June 2015
Hepatitis C treatment

NHS accused of delaying access to 'highly tolerable' hepatitis C drugs over cost concerns

Editor's pick
The Independent
17 June 2015
Hepatitis C symptoms & diagnosis

Hepatitis cases responsible for 93% of prison disease reports

Editor's pick
Public Health England press release
16 June 2015
Hepatitis C treatment

Prisoners Sue Massachusetts for Withholding Hepatitis C Drugs

Editor's pick
Wall Street Journal (blog)
16 June 2015
Hepatitis C treatment

NHS England announces 'huge investment' for new hepatitis C treatments

Editor's pick
The Pharmaceutical Journal
16 June 2015
Hepatitis C treatment

HCV at a Crossroads:The Pre- or Post-Transplant Treatment Debate

Editor's pick
Healio HCV Next
15 June 2015